BeiGene launches IPO on Shanghai’s STAR market to raise $3B

2021-12-03| ChinaIPO

BeiGene launches IPO on Shanghai’s STAR market to raise $3B

by Sahana Shankar

Share To

BeiGene Ltd announces the third round of its initial public offering (IPO) on the STAR market of Shanghai Stock Exchange to raise US $3.5 billion. The global biotech company, based in Beijing, China offers around 115 million ordinary shares, representing 8.62% of its total outstanding shares.

GO Prime with only $1.49 now

SUBSCRIBE NOW

LATEST

Vaccine Protecting Against 20 Different Pneumococcal Infections Proves Effective in Trial

2022-08-12

FDA Approves Roche’s Established Antiviral For Children Aged Five Or Older

2022-08-12

Novartis Reported Two Deaths Following Zolgensma Gene Therapy

2022-08-12

Extreme Climate Change Is Aggravating Infectious Diseases!

2022-08-11

In Response to Expanding Monkeypox Outbreak, FDA Approves Emergency Use of JYNNEOS Vaccine

2022-08-11

Potential $1 billion Acquisition of TeneoTwo by AstraZeneca comes to Fruition

2022-08-11

Gene Repair Therapy: First Patient Dosed With New Treatment for Sickle Cell Disease

2022-08-11

EVENT

2022-09-09

ESMO 2022 Exhibition

Online and on-side

2022-09-20

Cell & Gene Therapy USA 2022

Virtual

2022-09-21

CSCO Educational Book 2022

Xiamen

2022-09-21

RESI Boston

Boston

2022-09-26

Human Gene Therapy Conference

Australia

2022-11-07

2nd World Congress on Primary Healthcare and Medicare Summit

Paris, France

Cookie	Duration	Description
cookielawinfo-checbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

GENE ONLINE|News &
Opinion
Blog